Developer docs
API playgroundTry for free, no card

Search company profiles

SMT Research and Development

Full company profile

uuid003emx5

Namestring
SMT Research and Development
Websiteurl
smtmed.com
Company typeenum
Private
Founded yearint
2004
Descriptiontext

SMT Research and Development is an Israel-based medical device company, founded in 2004 and headquartered in Herzliya, that develops and commercializes procedural accessories used during Transcatheter Aortic Valve Implantation (TAVI) and other heart procedures. The company operates in the structural heart and interventional cardiology accessories category, supplying tools that interventional cardiologists and cardiac surgeons use adjunctively during transcatheter valve procedures. Its product surface is oriented around procedural enablement rather than implantable devices themselves, positioning SMT as a complementary supplier in the TAVI workflow alongside valve manufacturers and imaging/cath lab capital equipment vendors.

The company's commercial model appears to be B2B sales of single-use or limited-use medical accessories to hospitals and cardiac surgery centers, though the provided data does not disclose pricing, contract structures, distributor relationships, or specific product SKUs. In April 2011, SMT secured a $10.5 million financing round led by OrbiMed, a healthcare-specialist investor, which provided capital for product development and commercialization. The company's website (smtmed.com) is referenced as the corporate web property, although one indexed source shows the domain listed for sale on the Atom.com premium domain marketplace, introducing ambiguity about the company's current operating status.

The available data is thin on operational details: no headcount, management team, regulatory filings, patent portfolio, named customers, geographic footprint, or revenue figures are disclosed. This limits the ability to assess SMT's current scale, market share, or competitive position within the global TAVI accessories market, which has grown substantially since 2011 alongside the broader adoption of transcatheter valve therapies.

Short descriptiontext

SMT Research and Development is an Israel-based medical device company, founded in 2004 and based in Herzliya, that develops and commercializes procedural accessories used during TAVI and other heart procedures for interventional cardiology and cardiac surgery customers.

Ownership categoryenum
akta.pro rankint
HeadquartersHerzliya, Israel
HQ citystring
Herzliya
HQ countrystring
Israel
HQ regionstring
Middle East
Markets served

Serves global market

Keyword5 values
structural heart devices, cardiac procedural accessories, TAVI accessories, interventional cardiology, medical device development
SIC code1 code
  • Surgical & Medical Instruments & Apparatus3841
Product category
Structural Heart Medical Devices
No data
Cost components5 values
Technology or R&D, Supply Chain, Operations, Personnel, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

SMT Research and Development is a medical device company that develops and commercializes procedural accessories used during TAVI (Transcatheter Aortic Valve Implantation) and other heart procedures. Its offering consists of single-use accessory devices designed to support interventional cardiologists and cardiac surgeons performing transcatheter structural heart interventions. The company is based in Herzliya, Israel and was founded in 2004.

Differentiator
Functional benefit
Problem solved
Recent move1 record

Each record includes

Date, Type, Title, Description, Source

Expansion highlight1 record

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Active in structural heart through its WATCHMAN franchise and a portfolio of vascular access and closure accessories used in TAVI procedures. Comparable as a broad incumbent with overlapping TAVI accessory exposure.

TypeEmerging player
Description

Developer of transcatheter aortic and regurgitation valve systems with associated delivery accessories. Comparable as an emerging structural heart player addressing overlapping TAVI/TAVR clinical indications.

TypeEmerging player
Description

Early-stage developer of a transcatheter tricuspid repair technology delivered through dedicated procedural accessories. Comparable as an emerging structural heart company whose commercial success depends on the same interventional cardiology channels SMT serves.

TypeBroad incumbent
Description

Operates the CoreValve/Evolut TAVI platform and supplies associated procedural accessories across structural heart. Comparable as a broad incumbent that controls both valves and the accessory ecosystem around them.

5Venus Medtech
TypeRegional player
Description

Chinese TAVI developer with the VenusA and VenusP-Valve systems and a growing accessory portfolio. Comparable as a regional TAVI systems-and-accessories competitor, primarily serving Asia.

TypeEmerging player
Description

India-based developer of the Myval transcatheter heart valve system and related accessories. Comparable as an emerging TAVI player outside the dominant US/EU incumbents with a similar product-and-accessory focus.

TypeEmerging player
Description

Emerging developer of transcatheter mitral and tricuspid valve technologies with proprietary delivery accessory platforms. Comparable as an emerging structural heart device company investing in proprietary procedural accessory technology.

TypeDirect peer
Description

Global leader in TAVI/TAVR through its Sapien platform and also markets the Sentinel cerebral protection system, a TAVI procedural accessory. Directly comparable as a TAVI accessory developer and the dominant structural heart incumbent.

9Abbott
TypeBroad incumbent
Description

Markets the Portico TAVI system and adjacent structural heart devices including vascular closure and access products. Comparable as a broad incumbent operating across the structural heart procedure stack.

TypeDirect peer
Description

Markets the Manta vascular closure device, a leading dedicated accessory for large-bore TAVI access closure. Highly comparable as a focused supplier of procedural accessories in the same cath lab workflow.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights4 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

SMT Research and Development

Structural Heart Medical Devicessmtmed.com

SMT Research and Development is an Israel-based medical device company, founded in 2004 and based in Herzliya, that develops and commercializes procedural accessories used during TAVI and other heart procedures for interventional cardiology and cardiac surgery customers.

What SMT Research and Development does

SMT Research and Development is an Israel-based medical device company, founded in 2004 and headquartered in Herzliya, that develops and commercializes procedural accessories used during Transcatheter Aortic Valve Implantation (TAVI) and other heart procedures. The company operates in the structural heart and interventional cardiology accessories category, supplying tools that interventional cardiologists and cardiac surgeons use adjunctively during transcatheter valve procedures. Its product surface is oriented around procedural enablement rather than implantable devices themselves, positioning SMT as a complementary supplier in the TAVI workflow alongside valve manufacturers and imaging/cath lab capital equipment vendors.

The company's commercial model appears to be B2B sales of single-use or limited-use medical accessories to hospitals and cardiac surgery centers, though the provided data does not disclose pricing, contract structures, distributor relationships, or specific product SKUs. In April 2011, SMT secured a $10.5 million financing round led by OrbiMed, a healthcare-specialist investor, which provided capital for product development and commercialization. The company's website (smtmed.com) is referenced as the corporate web property, although one indexed source shows the domain listed for sale on the Atom.com premium domain marketplace, introducing ambiguity about the company's current operating status.

The available data is thin on operational details: no headcount, management team, regulatory filings, patent portfolio, named customers, geographic footprint, or revenue figures are disclosed. This limits the ability to assess SMT's current scale, market share, or competitive position within the global TAVI accessories market, which has grown substantially since 2011 alongside the broader adoption of transcatheter valve therapies.

SMT Research and Development firmographics

Firmographics
Name
SMT Research and Development
Website
https://smtmed.com
Company type
Private
Founded year
2004
Short description
SMT Research and Development is an Israel-based medical device company, founded in 2004 and based in Herzliya, that develops and commercializes procedural accessories used during TAVI and other heart procedures for interventional cardiology and cardiac surgery customers.
Ownership category
akta.pro rank

Where SMT Research and Development is headquartered

Location

Headquarters

HQ city
Herzliya
HQ country
Israel
HQ region
Middle East

Markets served

SMT Research and Development business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Supply Chain, Operations, Personnel, Marketing or Sales

SMT Research and Development product offering

Product offering

Core offering

SMT Research and Development is a medical device company that develops and commercializes procedural accessories used during TAVI (Transcatheter Aortic Valve Implantation) and other heart procedures. Its offering consists of single-use accessory devices designed to support interventional cardiologists and cardiac surgeons performing transcatheter structural heart interventions. The company is based in Herzliya, Israel and was founded in 2004.

Differentiator

Problem solved

Functional benefit

Companies that use SMT Research and Development

Customer profile

Ideal customer profiles1 record

SMT Research and Development technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

SMT Research and Development partnerships and signals

Strategic signal

Recent moves1 record

Expansion highlights1 record

SMT Research and Development competitors and assessment

Company assessment

Broad incumbents

  • Boston Scientific: Active in structural heart through its WATCHMAN franchise and a portfolio of vascular access and closure accessories used in TAVI procedures. Comparable as a broad incumbent with overlapping TAVI accessory exposure.
  • Medtronic: Operates the CoreValve/Evolut TAVI platform and supplies associated procedural accessories across structural heart. Comparable as a broad incumbent that controls both valves and the accessory ecosystem around them.
  • Abbott: Markets the Portico TAVI system and adjacent structural heart devices including vascular closure and access products. Comparable as a broad incumbent operating across the structural heart procedure stack.

Emerging players

  • JenaValve Technology: Developer of transcatheter aortic and regurgitation valve systems with associated delivery accessories. Comparable as an emerging structural heart player addressing overlapping TAVI/TAVR clinical indications.
  • CroiValve: Early-stage developer of a transcatheter tricuspid repair technology delivered through dedicated procedural accessories. Comparable as an emerging structural heart company whose commercial success depends on the same interventional cardiology channels SMT serves.
  • Meril Life Sciences: India-based developer of the Myval transcatheter heart valve system and related accessories. Comparable as an emerging TAVI player outside the dominant US/EU incumbents with a similar product-and-accessory focus.
  • 4C Medical Technologies: Emerging developer of transcatheter mitral and tricuspid valve technologies with proprietary delivery accessory platforms. Comparable as an emerging structural heart device company investing in proprietary procedural accessory technology.

Regional players

  • Venus Medtech: Chinese TAVI developer with the VenusA and VenusP-Valve systems and a growing accessory portfolio. Comparable as a regional TAVI systems-and-accessories competitor, primarily serving Asia.

Direct peers

  • Edwards Lifesciences: Global leader in TAVI/TAVR through its Sapien platform and also markets the Sentinel cerebral protection system, a TAVI procedural accessory. Directly comparable as a TAVI accessory developer and the dominant structural heart incumbent.
  • Teleflex: Markets the Manta vascular closure device, a leading dedicated accessory for large-bore TAVI access closure. Highly comparable as a focused supplier of procedural accessories in the same cath lab workflow.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat3 records

Key risks5 records

Key highlights4 records

Customer concentration

SMT Research and Development financial estimates

Financial estimate

Revenue estimate

Valuation estimate

SMT Research and Development leadership team

Management profile

Number of profiles

SMT Research and Development funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

SMT Research and Development M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SMT Research and Development

What does SMT Research and Development do?

SMT Research and Development is a medical device company that develops and commercializes procedural accessories used during TAVI (Transcatheter Aortic Valve Implantation) and other heart procedures. Its offering consists of single-use accessory devices designed to support interventional cardiologists and cardiac surgeons performing transcatheter structural heart interventions. The company is based in Herzliya, Israel and was founded in 2004.

When was SMT Research and Development founded?

SMT Research and Development was founded in 2004.

Where is SMT Research and Development based?

SMT Research and Development is headquartered in Herzliya, Israel, in the Middle East region.

Who are SMT Research and Development's main competitors?

Broad incumbents on record are Boston Scientific, Medtronic and Abbott. Emerging players are JenaValve Technology, CroiValve, Meril Life Sciences and 4C Medical Technologies. Venus Medtech is listed as a regional player. Direct peers are Edwards Lifesciences and Teleflex.

Does SMT Research and Development have an API?

No public API is recorded for SMT Research and Development.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales